(Q35590426)

English

A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension

scientific article published on January 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 August 2017

A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension (English)

1 reference

Europe PubMed Central

9 August 2017

multicenter clinical trial

0 references

author name string

S M Whitcup

1

1 reference

Europe PubMed Central

9 August 2017

L B Cantor

2

1 reference

Europe PubMed Central

9 August 2017

A M VanDenburgh

3

1 reference

Europe PubMed Central

9 August 2017

K Chen

4

1 reference

Europe PubMed Central

9 August 2017

language of work or name

0 references

publication date

1 January 2003

1 reference

Europe PubMed Central

9 August 2017

British Journal of Ophthalmology

1 reference

Europe PubMed Central

9 August 2017

87

1 reference

Europe PubMed Central

9 August 2017

1

1 reference

Europe PubMed Central

9 August 2017

57-62

1 reference

Europe PubMed Central

9 August 2017

The pharmacology of bimatoprost (Lumigan).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771463

12 July 2018

Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP : a 3-month clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771463

12 July 2018

Target pressures in glaucoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771463

12 July 2018

Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771463

12 July 2018

A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771463

12 July 2018

Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771463

12 July 2018

Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771463

26 September 2018

Target pressure--glaucomatologists' holey grail.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771463

26 September 2018

Comparison of the ocular hypotensive lipid AGN 192024 with timolol: dosing, efficacy, and safety evaluation of a novel compound for glaucoma management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771463

15 November 2018

Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771463

15 November 2018

Fluctuations of intraocular pressure during the day in open-angle glaucoma, normal-tension glaucoma and normal subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/12488264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12488264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/12488264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12488264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Presence and rapid decline of early morning intraocular pressure peaks in glaucoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12488264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A useful testing strategy in phase III trials: combined test of superiority and test of equivalence

1 reference

https://pubmed.ncbi.nlm.nih.gov/12488264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BJO.87.1.57

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35590426&oldid=1580722709"